Getinge AB ser. B (GETI-B) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Getinge AB ser. B (GETI-B) has a cash flow conversion efficiency ratio of 0.042x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr1.29 Billion ≈ $138.93 Million USD) by net assets (Skr31.00 Billion ≈ $3.34 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Getinge AB ser. B for the company's overall valuation and market capitalisation.
Getinge AB ser. B - Cash Flow Conversion Efficiency Trend (2002–2025)
This chart illustrates how Getinge AB ser. B's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Getinge AB ser. B Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Getinge AB ser. B ranked by their cash flow conversion efficiency. Explore GETI-B operating cash flow to net income to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Fibra UNO
MX:FUNO11
|
0.011x |
|
Janus Living, Inc.
NYSE:JAN
|
-0.009x |
|
The People's Insurance Company (Group) of China Limited
F:PIR
|
0.071x |
|
Lithia Motors Inc
NYSE:LAD
|
-0.017x |
|
Ternium SA DRC
BA:TXR
|
0.013x |
|
Cpi Property Group SA
XETRA:O5G
|
0.029x |
|
Bio-Rad Laboratories Inc
NYSE:BIO
|
0.016x |
|
Grupo Financiero Galicia S.A.
BA:GGAL
|
-0.138x |
Annual Cash Flow Conversion Efficiency for Getinge AB ser. B (2002–2025)
The table below shows the annual cash flow conversion efficiency of Getinge AB ser. B from 2002 to 2025. View latest Getinge AB ser. B stock price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Skr29.49 Billion ≈ $3.17 Billion |
Skr3.95 Billion ≈ $424.98 Million |
0.134x | -2.85% |
| 2024-12-31 | Skr33.21 Billion ≈ $3.57 Billion |
Skr4.58 Billion ≈ $492.56 Million |
0.138x | +41.70% |
| 2023-12-31 | Skr30.40 Billion ≈ $3.27 Billion |
Skr2.96 Billion ≈ $318.22 Million |
0.097x | -12.03% |
| 2022-12-31 | Skr30.45 Billion ≈ $3.28 Billion |
Skr3.37 Billion ≈ $362.34 Million |
0.111x | -57.57% |
| 2021-12-31 | Skr25.18 Billion ≈ $2.71 Billion |
Skr6.56 Billion ≈ $705.96 Million |
0.261x | -22.23% |
| 2020-12-31 | Skr21.49 Billion ≈ $2.31 Billion |
Skr7.20 Billion ≈ $774.73 Million |
0.335x | +83.38% |
| 2019-12-31 | Skr20.97 Billion ≈ $2.26 Billion |
Skr3.83 Billion ≈ $412.38 Million |
0.183x | +43.48% |
| 2018-12-31 | Skr19.66 Billion ≈ $2.12 Billion |
Skr2.50 Billion ≈ $269.36 Million |
0.127x | -8.71% |
| 2017-12-31 | Skr19.81 Billion ≈ $2.13 Billion |
Skr2.76 Billion ≈ $297.34 Million |
0.140x | -20.52% |
| 2016-12-31 | Skr20.92 Billion ≈ $2.25 Billion |
Skr3.67 Billion ≈ $395.06 Million |
0.176x | -0.56% |
| 2015-12-31 | Skr19.59 Billion ≈ $2.11 Billion |
Skr3.46 Billion ≈ $372.14 Million |
0.176x | -5.00% |
| 2014-12-31 | Skr18.69 Billion ≈ $2.01 Billion |
Skr3.47 Billion ≈ $373.75 Million |
0.186x | -13.19% |
| 2013-12-31 | Skr16.56 Billion ≈ $1.78 Billion |
Skr3.54 Billion ≈ $381.39 Million |
0.214x | -11.77% |
| 2012-12-31 | Skr15.20 Billion ≈ $1.64 Billion |
Skr3.69 Billion ≈ $396.78 Million |
0.243x | +1.55% |
| 2011-12-31 | Skr14.64 Billion ≈ $1.58 Billion |
Skr3.50 Billion ≈ $376.23 Million |
0.239x | -23.27% |
| 2010-12-31 | Skr13.25 Billion ≈ $1.43 Billion |
Skr4.12 Billion ≈ $443.81 Million |
0.311x | -2.24% |
| 2009-12-31 | Skr12.56 Billion ≈ $1.35 Billion |
Skr4.00 Billion ≈ $430.46 Million |
0.318x | +130.47% |
| 2008-12-31 | Skr10.68 Billion ≈ $1.15 Billion |
Skr1.48 Billion ≈ $158.73 Million |
0.138x | -31.10% |
| 2007-12-31 | Skr6.62 Billion ≈ $712.74 Million |
Skr1.33 Billion ≈ $142.91 Million |
0.201x | -19.97% |
| 2006-12-31 | Skr6.00 Billion ≈ $646.23 Million |
Skr1.50 Billion ≈ $161.91 Million |
0.251x | +15.30% |
| 2005-12-31 | Skr5.38 Billion ≈ $579.11 Million |
Skr1.17 Billion ≈ $125.84 Million |
0.217x | -12.18% |
| 2004-12-31 | Skr4.27 Billion ≈ $459.48 Million |
Skr1.06 Billion ≈ $113.69 Million |
0.247x | -36.98% |
| 2003-12-31 | Skr3.53 Billion ≈ $379.93 Million |
Skr1.39 Billion ≈ $149.17 Million |
0.393x | +2.36% |
| 2002-12-31 | Skr3.16 Billion ≈ $339.87 Million |
Skr1.21 Billion ≈ $130.37 Million |
0.384x | -- |
About Getinge AB ser. B
Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments in Sweden and internationally. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, advanced patient monitoring, ICU infrastructure equipment, and drainage solu… Read more